15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?
- PMID: 12975467
- PMCID: PMC193674
- DOI: 10.1172/JCI19796
15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?
Abstract
15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) affects gene transcription by activating PPARgamma and by covalent addition to transcription factors and signaling molecules, However, it is not known whether the high concentrations of 15d-PGJ2 required for these responses are consistent with physiological levels. A new study suggests that in vivo 15d-PGJ2 levels are actually several orders of magnitude below the levels required to induce many of the biological effects attributed to this molecule.
Figures
Comment on
-
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.J Clin Invest. 2003 Sep;112(6):945-55. doi: 10.1172/JCI18012. J Clin Invest. 2003. PMID: 12975479 Free PMC article.
References
-
- Fitzpatrick FA, Wynalda MA. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J. Biol. Chem. 1983;258:11713–11718. - PubMed
-
- Forman BM, et al. 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-γ. Cell. 1995;83:803–812. - PubMed
-
- Kliewer SA, et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor-γ and promotes adipocyte differentiation. Cell. 1995;83:813–819. - PubMed
-
- Murphy GJ, Holder JC. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol. Sci. 2000;21:469–474. - PubMed
